期刊文献+

大鼠移植静脉再狭窄过程中黏着斑激酶的活化及奥美沙坦的干预作用 被引量:2

The Phosphorylation of Focal Adhesion kinase in The Restenosis of Rat's Vein Graft:Modulation by Olmesartan
下载PDF
导出
摘要 目的研究黏着斑激酶(FAK)在大鼠移植静脉再狭窄过程中的作用,并研究奥美沙坦的干预效应。方法建立大鼠颈外静脉移植模型,将40只雄性大鼠随机分成:1)假手术组;2)模型组;3)奥美沙坦组;4)生理盐水组等4组。观察各组血管壁内膜厚度及内膜/中膜(I/M);采用免疫组化方法观察各组血管平滑肌细胞增殖核抗原(PCNA)及平滑肌肌动蛋白(α-SM actin)表达;采用 western-blot 方法检测 FAK 及磷酸化 FAK 的表达。结果模型组与假手术组相比,内膜明显增厚(P<0.01),I/M 明显增加(P<0.01),PCNA 表达明显增加(P<0.01),α-SMactin、FAK、磷酸化 FAK 叫显增加(P<0.05);奥美沙坦组与模型组相比,内膜厚度、I/M 明显减轻(P<0.05),PC-NA、α-SM actin、磷酸化 FAK 表达明显降低(P<0.05)。结论 FAK 活化参与了大鼠移植静脉再狭窄过程,奥美沙坦可以抑制大鼠移植静脉再狭窄,这种作用可能与减轻局部 FAK 活化有关。 Objective To study the expression and phosphorylation of focal adhesion kinase(FAK) in rat's autologous vein graft and the olmesartan modulating effect. Methods Autologous external jugular veins were grafted to common carotid arteries in 40 male Sprague Dawley rats. After surgery, rats were randomly assigned to the fol- lowing groups: sham;control;olmesartan treatment( 10mg/kg. d by gavage); or physiological saline. The intimal thickness, the I/M in vein grafts was quantitated by HE stain. The expression and phosphorylation of focal adhesion kinase were assessed by Western-blotting, PCNA and α-smooth muscle actin were measured by immunohistochemistry. Results Neointimal hyperplasia in control group was characterized by significantly increased intimal thickeness I/M(P〈0.01 ). The expression of FAK, phosphorylated FAK, PCNA and α-smooth muscle actin in model control group were significantly higher than in the sham group (P〈0. 05 ); Compared to the control group, olmesartan significantly attenuated intimal thickness and I/M( P〈0. 05), and the reduced the expression of phosphorylated FAK, α-smooth muscle actin and PCNA(P〈0. 05). Conclusion The phosphorylation of FAK was associated with the restenosis of rat's vein graft; Olmesartan attenuate the restenosis and downregulated FAK local expression.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2008年第3期235-238,共4页 Chinese Journal of Hypertension
关键词 奥美沙坦 再狭窄 黏着斑激酶 磷酸化 Olmesartan Restenosis Focal adhesion kinase Phosphorylation
  • 相关文献

参考文献10

  • 1[2]Yoshida Y,Mitsumata M,Ling G,et al.Migration of medial smooth muscle cells to the intima after balloon injury[J].Ann N Y Acad Sci.1997,8:459-470.
  • 2温进坤,韩梅,程云会,杨长春,刘智敏.整合素β_3-粘着斑激酶信号途径的活化参与大鼠血管新生内膜的形成[J].中国病理生理杂志,2006,22(10):1922-1925. 被引量:5
  • 3[4]Govindarajan G,Eble DM,Lucchesi PA,et al.Focal adhesionkinase is involved in angiotensin Ⅱ mediated protein synthesis in cultured vascular smooth muscle cells[J].Circulation Research,2000,87:710-716.
  • 4[5]Le Boeuf F,Houle F,Sussman M,et al.Phosphorylation of focal adhesion kinase(FAK)on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor[J].Mol Biol Cell,2006,17:3508-3520.
  • 5[6]Angelucci A,Bologna M.Targeting vascular cell migration as a strategy for blocking angiogenesis:the central role of focal adhesion protein tyrosine kinase family[J].Curr Pharm Des,2007,13:2129-2145.
  • 6[7]Mehta PK,Griendling KK.Angiotensin Ⅱ cell signaling:physiological and pathological effects in the cardiovascular system[J].Am J Physiol Cell Physiol,2007,292:C82-C97.
  • 7[8]Furubayashi K,Takai S,Jin D,et al.The significance of chymase in the progression of abdominal aortic aneurysms in dogs[J].Hypertens Res,2007,30:349-357.
  • 8[9]Koike H,Sada T,Mizuno M.In vitro and invivo pharmacology of olmesartan medoxomil,an angiotensin Ⅱ type AT1 receptor antagonist[J].J Hypertens,2001,19:S3-14.
  • 9[10]Warner GT,Jarvis B.Olmesartan medoxomil[J].Drugs,2002,62:1345-1353.
  • 10贾楠,黄秋萍,金炜,张建军,孙宝贵.奥美沙坦与替莫普利合用对逆转左心室肥厚无协同作用[J].中华高血压杂志,2007,15(4):285-288. 被引量:2

二级参考文献22

  • 1诸骏仁,蔡迺绳,范维琥,朱鼎良,何奔,吴宗贵,柯元南,郭静萱,马虹,黄峻,李新立,陈运贞.奥美沙坦治疗轻、中度原发性高血压病人的疗效与安全性总结[J].中国新药与临床杂志,2006,25(3):236-237. 被引量:16
  • 2[2]Clark EA,Brugg JS.Integrins and signal transduction pathways:the road taken[J].Science J,1995,268:233-239.
  • 3[3]Pham CG,Harpf AE,Keller RS,et al.Striated muscle-specific β-1 D-integrin and FAK are involved in cardiac myocytes hypertrophic response pathway[J].Am J Heart Circ Physiol,2000,279:2916-2926.
  • 4[4]Otsuka S,Sugano M,Makino N,et al.Interaction of mRNAs for angiotensin Ⅱ type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats[J].Hypertension,1998,32:467-472.
  • 5[5]Sugimoto K,Fujimura A.Role of bradykinin in the reduction of left ventricular hypertrophy induced by angiotensinconverting enzyme inhibitors in spontaneously hypertensive rats[J].Jpn J Pharmacol,1998,76:431-434.
  • 6[6]Hu K,Gaudron P,Anders HJ,et al.Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1 receptor subtype blocked in rats with myocardial infarction:role of bradykinin[J].Cardovasc Res,1998,39:401-412.
  • 7[7]Funabiki K,Onishi K,Dohi K,et al.Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure[J].Am J Heart Circ Physiol,2004,287:H2487-2492.
  • 8[8]Sanada S,Kitakaze M,Node K,et al.Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats[J].Hypertension,2001,38:404-411.
  • 9[9]Eisenberg MJ,Gioia LC.Angiotensin Ⅱ receptor blockers in congestive heart failure[J].Cardiol Rev,2006,14:26-34.
  • 10[10]Kawano H,Cody RJ,Graf K,et al.Angiotensin Ⅱ enhances integrin and α-actinin expression in adult rat cardiac fibroblasts[J].Hypertension,2000,35:273-279.

共引文献5

同被引文献4

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部